A detailed history of North Capital, Inc. transactions in Organon & Co. stock. As of the latest transaction made, North Capital, Inc. holds 104 shares of OGN stock, worth $783. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Previous 103 0.97%
Holding current value
$783
Previous $997,000 11.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

BUY
$8.4 - $10.85 $8 - $10
1 Added 0.97%
104 $1.11 Million
Q2 2025

Aug 06, 2025

SELL
$8.04 - $14.72 $1,760 - $3,223
-219 Reduced 68.01%
103 $997,000
Q1 2025

Apr 28, 2025

BUY
$14.29 - $16.41 $4,601 - $5,284
322 New
322 $4.8 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track North Capital, Inc. Portfolio

Follow North Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on North Capital, Inc. with notifications on news.